Ardelyx | ARDX - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 8.52B 1.01B 2025-12
Amgen USD 9.13B 316M 2025-12
Ardelyx USD 68M 25.28M 2025-12
aTyr Pharma USD 6.15M 11.07M 2025-09
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Curis USD 10.14M 10.14M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
TG Therapeutics USD 199.51M 21.2M 2025-12
United Therapeutics USD 1.56B 217M 2025-12
Xoma USD 143.9M 7.68M 2024-06